| NPASS database update 2023: quantitative natural product activity and species source database for biomedical research H Zhao, Y Yang, S Wang, X Yang, K Zhou, C Xu, X Zhang, J Fan, D Hou, ... Nucleic Acids Research 51 (D1), D621-D628, 2023 | 28 | 2023 |
| GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis X Ye, P Zhang, Y Zhang, J Luan, C Xu, Z Wu, D Ju, W Hu Frontiers in Immunology 13, 893914, 2022 | 17 | 2022 |
| Cell membrane-derived vesicle: A novel vehicle for cancer immunotherapy C Xu, D Ju, X Zhang Frontiers in Immunology 13, 923598, 2022 | 16 | 2022 |
| Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer C Xu, D Ju, X Zhang Antibody Therapeutics 5 (1), 73-83, 2022 | 12 | 2022 |
| Interleukin-22 in renal protection and its pathological role in kidney diseases Q Ma, J Luan, Y Bai, C Xu, F Liu, B Chen, D Ju, H Xu Frontiers in Immunology 13, 851818, 2022 | 11 | 2022 |
| A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease X Hu, J Fan, Q Ma, L Han, Z Cao, C Xu, J Luan, G Jing, Y Nan, T Wu, ... Journal of Nanobiotechnology 20 (1), 237, 2022 | 10 | 2022 |
| TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer C Xu, M Zhu, Q Wang, J Cui, Y Huang, X Huang, J Huang, J Gai, G Li, ... Journal of Nanobiotechnology 21 (1), 410, 2023 | 9 | 2023 |
| Innate immunity in cancer biology and therapy Y Zhang, W Xue, C Xu, Y Nan, S Mei, D Ju, S Wang, X Zhang International Journal of Molecular Sciences 24 (14), 11233, 2023 | 6 | 2023 |
| Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma Y Wang, X Zhang, C Xu, Y Nan, J Fan, X Zeng, BS Kwon, D Ju Frontiers in Immunology 13, 1004475, 2022 | 2 | 2022 |
| Targeting CD47 enhanced the antitumor immunity of PD-L1 blockade in B-cell lymphoma Y Nan, X Zhang, S Wang, C Xu, Y Wang, L Han, J Luan, X Hu, W Chen, ... Immunotherapy 15 (3), 175-187, 2023 | 1 | 2023 |
| Enhancing antitumor efficacy of CLDN18. 2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer W Xue, C Xu, K Zhang, L Cui, X Huang, Y Nan, D Ju, X Chang, X Zhang Cell Death Discovery 10 (1), 393, 2024 | | 2024 |
| Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer K Zhang, Y Xu, X Chang, C Xu, W Xue, D Ding, M Nie, H Cai, J Xu, L Zhan, ... Cancer Immunology, Immunotherapy 73 (4), 75, 2024 | | 2024 |
| Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis Y Zhang, W Xin, X Hu, H Wang, X Ye, C Xu, Y Nan, Z Wu, D Ju, J Fan Cell Death & Disease 14 (11), 740, 2023 | | 2023 |
| Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II C Xu, D Ju, X Zhang Frontiers in Immunology 14, 1256691, 2023 | | 2023 |
